Serum VEGF-D has potential prognostic relevance in LAM, with elevated levels being associated with the severity of the pulmonary impairment, reduced exercise tolerance, and the presence of lymphangioleiomyomas or lymphadenopathy.30 This evidence concerns the gene VEGFD and lymphangioleiomyomatosis.